Gallbladder and Bile Duct Cancer With Liver Fluke: How the Two Cancers Differ, Why Jaundice Happens, Treatment Options, and 4 Nutrition Steps for Patients and Families

A reader’s story: a father just diagnosed with gallbladder cancer and liver fluke

A community member asked people who had been through this to share their experience of treating gallbladder cancer linked to liver fluke, because her father had just been diagnosed.
The family is unsure what the disease is, how it is treated, and how to look after his diet.

This article does not diagnose anyone. It answers the questions families most often ask: how gallbladder cancer differs from bile duct cancer,
how much the liver fluke matters, why jaundice happens and why a stent is needed, what the treatment options are, and what to eat, based on research indexed in PubMed.

1. How Gallbladder Cancer Differs From Bile Duct Cancer

Two cancers in one group, with different risk factors

Biliary tract cancer includes gallbladder cancer and bile duct cancer, which is divided by location into intrahepatic, perihilar, and distal types near the pancreas (Banales 2020).
Bile duct cancer accounts for about 15% of primary liver cancers worldwide. Gallbladder cancer (Hundal 2014) is most strongly linked to gallstones and chronic inflammation,
and usually causes no symptoms until it has spread. Overall 5-year survival is about 5%, although cancers found by chance during gallbladder removal for stones are usually at an earlier stage.

Tumor location changes the surgery

The phrase “gallbladder cancer from liver fluke” may mean a true gallbladder cancer, or a bile duct cancer that has grown into the gallbladder, which is far more common in northeastern Thailand.
Both use the same chemotherapy when advanced, but the surgery is very different. The first question for the doctor is therefore “Where did the tumor start, and can it be removed?”

Summarized from Banales 2020, Hundal 2014, and Vogel 2023. Actual symptoms depend on the size and location of each person’s tumor.

2. How Liver Fluke Is Linked to Cancer

A Group 1 carcinogen that works through chronic inflammation

The International Agency for Research on Cancer of the World Health Organization (Bouvard 2009) classifies the liver fluke Opisthorchis viverrini as a Group 1 carcinogen.
The fluke enters the body through undercooked freshwater fish and can live in the bile ducts for years. Work from the Khon Kaen group (Sripa 2007)
explains that the fluke injures the duct wall, its secreted products drive cell division, and chronic inflammation produces free radicals that repeatedly damage DNA until some cells become cancerous.
Liver fluke is most clearly linked to bile duct cancer; evidence linking parasitic infection to gallbladder cancer is weaker, and gallbladder cancer is tied more closely to gallstones.

Thailand has the highest bile duct cancer rate in the world

Thailand remains the country with the highest incidence of bile duct cancer in the world, in the northeast and in some northern provinces (Sripa 2008).
The CASCAP screening program (Khuntikeo 2015) reported 135.4 cases per 100,000 men and 43.0 per 100,000 women in Khon Kaen Province.
Among 85,927 people screened, 89.1% had eaten raw fish, 29.9% had a relative with bile duct cancer, and 42.2% of those tested for the fluke were still infected.

Fluke-related cancers carry different gene changes

A genetic study of 489 bile duct cancers from 10 countries (Jusakul 2017) found that fluke-related cancers more often carry ERBB2 (HER2) amplification and TP53 mutations,
while cancers unrelated to the fluke more often carry IDH1/2, BAP1, and FGFR2 changes. This matters in practice, because each targeted drug is designed for a specific gene change.

What family members should do

Family members who have shared the same food for years carry a similar risk. Eat only fully cooked freshwater fish; raw fish salad, raw fermented fish, and unheated fermented fish paste still carry the fluke.
People who have eaten raw fish regularly should ask a doctor about a stool test for fluke eggs and a liver ultrasound, which is the CASCAP approach in high-risk areas.
Deworming medicine does not treat the cancer. Praziquantel kills flukes that are still present, but reinfection follows if raw fish is still eaten, so yearly tablets cannot replace stopping raw fish.

3. Why Yellow Skin and Eyes, Itching, and Bloating Happen

The tumor blocks the bile duct, so bile backs up into the blood

The liver makes about 500–600 mL of bile a day, which travels through the bile ducts to the gallbladder and into the intestine to help digest fat. When a tumor presses on or blocks a bile duct, bile builds up and the yellow pigment bilirubin backs up into the bloodstream.
The patient develops yellow skin and eyes, tea-colored urine, clay-colored stools, and whole-body itching from bile acids retained under the skin.
Without bile in the intestine, fat is poorly digested, causing bloating, greasy stools, and poor appetite.

Stagnant bile infects easily

Bile that cannot flow becomes a breeding ground for bacteria. Infected bile duct inflammation (cholangitis) causes fever, chills, jaundice, and pain under the right ribs. The Tokyo Guidelines 2018 (Gomi 2018)
combine antibiotics with biliary drainage as the core treatment. This is why a patient who develops fever after a stent must go to hospital immediately: the stent may be blocked.

Biliary drainage: endoscopic stent or a drain through the skin

The European Society of Gastrointestinal Endoscopy (Dumonceau 2018) does not recommend draining bile before surgery in every case,
but advises it when there is cholangitis, severe itching, a long wait for surgery, or planned chemotherapy before surgery. For people who cannot have surgery, it recommends an endoscopic self-expanding metal stent, which blocks later than a plastic stent.
If the tumor is at the liver hilum or endoscopy is not possible, the doctor may place a drain through the skin into the liver, with an external bag to collect bile.
After successful drainage, jaundice and itching usually ease over days to weeks, and chemotherapy usually waits until the jaundice level has fallen.

Long-standing jaundice makes bleeding easier

Vitamins K, A, D, and E need bile to be absorbed. When the bile duct is blocked for a long time, the body runs low on vitamin K and blood clots more slowly, so doctors usually check clotting tests and may give vitamin K before procedures.

4. Treatment Options: Surgery, Chemotherapy, Immunotherapy, and Targeted Drugs

Surgery is the only way to remove the whole tumor, but few qualify

In biliary tract cancer, only about 20% of patients can have surgery (Primrose 2019), because most cancers are found after they reach major blood vessels, both sides of the liver, or distant organs.
Doctors therefore review CT or MRI scans before deciding. For gallbladder cancer, surgery removes the gallbladder with the adjoining liver tissue and lymph nodes.
Bile duct cancer may need part of the liver removed or removal of the head of the pancreas, which is major surgery, so strength and nutrition before surgery matter.

After surgery: oral capecitabine for about 6 months

The BILCAP trial of 447 people after surgery (Primrose 2019) found median survival of 51.1 months with capecitabine versus 36.4 months with observation (HR 0.81).
The main result did not reach statistical significance, but the per-protocol analysis showed a clearer benefit (HR 0.75), so the 2023 ESMO guideline (Vogel 2023) recommends capecitabine after surgery.
Common side effects are red, peeling hands and feet (20%) and diarrhea.

When surgery is not possible: gemcitabine with cisplatin plus immunotherapy

The ABC-02 trial of 410 people (Valle 2010) showed that gemcitabine with cisplatin raised median survival from 8.1 to 11.7 months (HR 0.64).
The TOPAZ-1 trial of 685 people (Oh 2022) then added the immunotherapy drug durvalumab and found 2-year survival of 24.9% versus 10.4% (HR 0.80),
and KEYNOTE-966 in 1,069 people (Kelley 2023) added pembrolizumab, with median survival of 12.7 versus 10.9 months (HR 0.83).
Both trials included gallbladder and bile duct cancers. Immunotherapy is costly and coverage differs between health schemes, so ask the hospital about coverage before starting.

Data from Oh 2022 (TOPAZ-1) and Lamarca 2021 (ABC-06). Figures are group averages, not an individual prediction.

Testing the tumor’s genes to look for targeted drugs

The 2023 ESMO guideline recommends gene testing of the tumor in advanced disease to look for changes with specific drugs, such as FGFR2, IDH1, HER2, BRAF V600E, and MSI-high.
Targeted drugs work only when a matching gene change is found, and according to Jusakul 2017, fluke-related cancers carry FGFR2 and IDH1 changes less often but may carry HER2 changes more often.
Gene testing therefore shows whether extra drug options exist; not everyone will have this option.

When the cancer grows after the first treatment

The ABC-06 trial of 162 people (Lamarca 2021) found that FOLFOX chemotherapy plus symptom care raised 1-year survival from 11.4% to 25.9%,
but severe side effects occurred in 69% versus 52%. The decision about second-line treatment should therefore include the goals and quality of life the patient wants.

Early palliative care is not stopping treatment

A randomized trial of 151 people with advanced lung cancer (Temel 2010) found that seeing a palliative care service from diagnosis, alongside usual cancer treatment,
improved quality of life, reduced depression (16% vs 38%), and lengthened median survival (11.6 vs 8.9 months). Although the data come from lung cancer, the principles of controlling pain, itching, and nausea and planning with the family apply to biliary tract cancer.

5. 4 Nutrition and Home-Care Steps

Step 1: Cut heavy fats, but there is no need to cut out all fat

When the bile duct is blocked, fried food, coconut milk, and fatty pork often cause bloating and greasy stools. Reduce these foods and spread small amounts of fat across several meals.
But there is no need to cut out all fat, because fat is the most concentrated energy source and cutting nearly all of it leaves too little energy and weight keeps falling.
A dietitian may use medium-chain triglyceride (MCT) oil, which is absorbed without needing much bile. After successful drainage, many patients can eat more fat again.

Step 2: Set calorie and protein targets, in 5–6 small meals

ESPEN guidance (Muscaritoli 2021) recommends 25–30 kcal and 1.0–1.5 g of protein per kg of body weight per day.
A person weighing 50 kg therefore needs about 1,250–1,500 kcal and about 50–75 g of protein a day. When fullness comes early, 5–6 small meals deliver more total energy.
Whole eggs, steamed fish, chicken, tofu, and low-fat milk are easy-to-digest proteins, and there is no need to eat only egg whites. If targets are not met, an oral nutrition supplement can fill the gap.

Step 3: Check skin color, fever, stools, and weight every day

Record temperature, eye color, urine color, stool color, and weight each morning. Fever or yellow eyes that return after a stent are signs to go to hospital immediately.
People with a drain through the skin should record daily bile output, drink enough fluid, and keep the skin around the drain clean. Itching may ease with lukewarm showers, moisturizing cream, short nails, and medicines prescribed by the doctor.

Step 4: Care for the minds of both patient and caregiver

The weeks after diagnosis bring many decisions at once. Choose one family member to coordinate with the treatment team, write questions down before appointments, and let the patient take part in choosing the treatment plan.
Listening and being present help the patient cope, and caregivers need rest too. If exhaustion or poor sleep lasts, ask to see the palliative care service or a psychologist.

Summarized from Muscaritoli 2021 and the physiology of fat digestion. Actual amounts must be adjusted for liver tests, kidney function, blood sugar, and dietitian advice.

Comparison of Treatment and Care Options

Only generic drug names or drug classes are used, never brand names. Treatment choices require assessment by the treatment team.

Common Beliefs Compared With the Evidence

“Liver fluke directly causes gallbladder cancer”

The clearest evidence is for bile duct cancer. Gallbladder cancer is tied more closely to gallstones and chronic inflammation, and what is called gallbladder cancer is sometimes a bile duct cancer that has spread there.

“Deworming tablets will shrink the tumor”

Deworming medicine kills the fluke but does not treat cancer cells that have already formed. The cancer still needs surgery or chemotherapy according to its stage.

“All fat must be stopped, and only egg whites eaten”

Cutting fried food and coconut milk reduces bloating during jaundice, but cutting all fat leaves too little energy. Whole eggs provide more energy and are digested well by most people.

“Once a stent is in, the cancer has been treated”

A stent relieves the blockage and jaundice and makes the body ready for treatment, but it does not destroy the tumor. Surgery or drug treatment still needs to be planned.

“If surgery is not possible, nothing more can be done”

Most patients cannot have surgery, but chemotherapy with immunotherapy improved survival in randomized trials, and symptom care improves quality of life.

Frequently Asked Questions (FAQ)

How does liver fluke lead to gallbladder or bile duct cancer?

The liver fluke lives inside the bile ducts, causing chronic inflammation of the duct lining and repeated DNA damage over many years. The International Agency for Research on Cancer of the World Health Organization classifies this fluke as a Group 1 carcinogen. The clearest evidence is for bile duct cancer, while gallbladder cancer is linked more to gallstones and chronic inflammation, so ask the doctor whether the tumor started in the gallbladder or in a bile duct.

How is gallbladder cancer different from bile duct cancer?

Both belong to the biliary tract cancer group and use the same chemotherapy when advanced, but they differ in location, risk factors, and surgery. Gallbladder cancer surgery removes the gallbladder with part of the liver and nearby lymph nodes, while bile duct cancer surgery depends on tumor location, such as a partial liver resection or removal of the head of the pancreas with the first part of the small intestine. In northeastern Thailand, bile duct cancer is far more common than gallbladder cancer.

Why do patients get yellow skin and eyes, itching, and bloating?

The tumor presses on or blocks the bile duct, so bile cannot reach the intestine and backs up into the bloodstream. This causes yellow skin and eyes, dark urine, pale stools, and itching from retained bile acids. Without bile in the intestine, fat is poorly digested and absorbed, causing bloating and greasy stools. These symptoms usually improve after successful biliary drainage.

Does everyone need a biliary stent or drain, and which type?

Not everyone. European guidance recommends draining bile before surgery only when there is infected bile duct inflammation, severe itching, a long wait for surgery, or planned chemotherapy before surgery. For people who cannot have surgery, an endoscopic metal stent is the main method. If endoscopy is not possible, the doctor may place a drain through the skin into the liver, and chemotherapy usually waits until the jaundice level falls.

Can the cancer be removed by surgery, and what if it cannot?

Only about 20 percent of people with biliary tract cancer can have the tumor removed. After surgery, oral capecitabine is usually given for about 6 months. If surgery is not possible, standard treatment is gemcitabine with cisplatin plus an immunotherapy drug; in a study of 685 people, 2-year survival was 24.9 percent compared with 10.4 percent with chemotherapy alone, together with early symptom care.

Does deworming medicine treat the cancer, and what should family members check?

Deworming medicine does not treat the cancer. Praziquantel kills flukes that are still present but does not shrink the tumor, and reinfection happens if raw freshwater fish is still eaten. Family members who have eaten raw fish salad, fermented raw fish, or unheated fish sauce paste should ask a doctor about a stool test for fluke eggs and a liver ultrasound, and should eat only fully cooked freshwater fish.

Must all fat be cut out, and should the patient eat only egg whites?

There is no need to cut out all fat. When the bile duct is blocked, reduce fried food and coconut milk and spread small amounts of fat across several meals, but cutting nearly all fat leaves too little energy and weight keeps falling. Whole eggs provide more energy than egg whites alone. ESPEN guidance recommends 25 to 30 kilocalories and 1.0 to 1.5 grams of protein per kilogram of body weight per day.

Which symptoms need urgent hospital care?

Fever or chills with yellow skin or pain under the right ribs, jaundice that deepens quickly after a stent, drowsiness or confusion, vomiting blood or black stools, sudden severe abdominal pain or rapid swelling, vomiting so much that eating and drinking are impossible, a drain that falls out or stops draining bile, and thoughts of self-harm.

Scientific Mechanism: From a Fluke in the Bile Duct to Jaundice and Weight Loss

Summary by Asst. Prof. Dr. Norawit Raatpiboon:
The liver fluke attaches to and feeds on the bile duct lining, causing repeated injury. Its secreted products push cells to divide quickly to repair the damage, while inflammatory white cells release nitric oxide and free radicals
that damage DNA. Years of rapid cell division on repeatedly damaged DNA open the way to mutations such as TP53 changes and ERBB2 amplification, until cells become bile duct cancer.

When the tumor narrows a bile duct, stagnant bile pushes bilirubin and bile acids back into the blood, causing jaundice and itching. An intestine without bile digests fat poorly and absorbs fat-soluble vitamins poorly,
and inflammatory signals from the tumor suppress appetite and speed muscle breakdown, so the patient loses appetite and weight. Care must therefore run in parallel: draining bile, treating the cancer, controlling infection, and providing digestible calories and protein.

Related Guides

E-E-A-T and Academic Citations

1. Bouvard V, et al. A review of human carcinogens – Part B: biological agents. Lancet Oncol. 2009. PubMed 19350698
2. Sripa B, et al. Liver fluke induces cholangiocarcinoma. PLoS Med. 2007. PubMed 17622191
3. Sripa B, Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 2008. PubMed 18408464
4. Khuntikeo N, et al. Cohort profile: cholangiocarcinoma screening and care program (CASCAP). BMC Cancer. 2015. PubMed 26054405
5. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014. PubMed 24634588
6. Banales JM, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020. PubMed 32606456
7. Jusakul A, et al. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 2017. PubMed 28667006
8. Vogel A, et al. Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023. PubMed 36372281
9. Primrose JN, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP). Lancet Oncol. 2019. PubMed 30922733
10. Valle J, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010. PubMed 20375404
11. Oh DY, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022. PubMed 38319896
12. Kelley RK, et al. Pembrolizumab in combination with gemcitabine and cisplatin for advanced biliary tract cancer (KEYNOTE-966). Lancet. 2023. PubMed 37075781
13. Lamarca A, et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06). Lancet Oncol. 2021. PubMed 33798493
14. Dumonceau JM, et al. Endoscopic biliary stenting: indications, choice of stents, and results: ESGE Clinical Guideline. Endoscopy. 2018. PubMed 30086596
15. Gomi H, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018. PubMed 29090866
16. Muscaritoli M, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021. PubMed 33946039
17. Temel JS, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010. PubMed 20818875

Medical Disclaimer